NEJM at ESMO - Pembrolizumab in HER2+ Gastric Cancer. Rubin EJ, Yeku OO, Morrissey S. N Engl J Med 2024 Sep 14. doi: 10.1056/NEJMe2411493.

Read + Share

Amedeo Smart

Independent Medical Education

Rubin EJ, Yeku OO, Morrissey S. NEJM at ESMO - Pembrolizumab in HER2+ Gastric Cancer. N Engl J Med 2024 Sep 14. doi: 10.1056/NEJMe2411493.
PMID: 39282936